CD44 and lung carcinoma: Although other HA-binding proteins are upregulated in lung cancer including CD44, RHAMM, and LYVE-1 (65–69); to the best of our knowledge, this is the first report of a functional role of HABP2 in HA-mediated lung cancer progression.